Literature DB >> 1581749

Fluoxetine improves emotional incontinence.

G M Seliger1, A Hornstein, J Flax, J Herbert, K Schroeder.   

Abstract

Emotional incontinence is a behavioural syndrome characterized by involuntary weeping, grimacing, and/or laughter. We investigated the efficacy of fluoxetine in 13 patients with emotional incontinence. All 13 patients demonstrated dramatic improvement in emotional lability within 3 to 14 days.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1581749     DOI： 10.3109/02699059209029668

Source DB:  PubMed          Journal:  Brain Inj        ISSN： 0269-9052            Impact factor:   2.311


  13 in total

1.  Pseudobulbar affect: prevalence and quality of life impact in movement disorders.

Authors:  Roy E Strowd; Michael S Cartwright; Michael S Okun; Ihtsham Haq; Mustafa S Siddiqui
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

2.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 3.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 4.  Treatment of uncontrolled crying after stroke.

Authors:  G Andersen
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 5.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

6.  [Amyotrophic lateral sclerosis: management of bulbar symptoms].

Authors:  P Kraft; M Beck; A Grimm; C Wessig; K Reiners; K V Toyka
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

7.  The causes and treatment of pseudobulbar affect in ischemic stroke.

Authors:  Preethi Balakrishnan; Howard Rosen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

8.  Stroke and depression: clinical features and treatment.

Authors:  R Torta; A Cicolin; R Keller
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 9.  Dextromethorphan/quinidine sulfate for pseudobulbar affect.

Authors:  Howard Rosen
Journal:  Drugs Today (Barc)       Date:  2008-09       Impact factor: 2.245

Review 10.  Neuropsychiatric syndromes associated with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.